These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 36813087

  • 1. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
    Fröberg G, Maurer FP, Chryssanthou E, Fernström L, Benmansour H, Boarbi S, Mengshoel AT, Keller PM, Viveiros M, Machado D, Fitzgibbon MM, Mok S, Werngren J, Cirillo DM, Alcaide F, Hyyryläinen HL, Aubry A, Andres S, Nadarajan D, Svensson E, Turnidge J, Giske CG, Kahlmeter G, Cambau E, van Ingen J, Schön T, EUCAST AMST and ESCMYC study groups.
    Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G, Wu L, Zheng Q, Jiang X.
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [Abstract] [Full Text] [Related]

  • 3. Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.
    Maurer FP, Pohle P, Kernbach M, Sievert D, Hillemann D, Rupp J, Hombach M, Kranzer K.
    Clin Microbiol Infect; 2019 Mar; 25(3):379.e1-379.e7. PubMed ID: 29906595
    [Abstract] [Full Text] [Related]

  • 4. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study.
    Ruedas-López A, Tato M, Broncano-Lavado A, Esteban J, Ruiz-Serrano MJ, Sánchez-Cueto M, Toro C, Domingo D, Cacho J, Barrado L, López-Roa P.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0504122. PubMed ID: 37212700
    [Abstract] [Full Text] [Related]

  • 5. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY.
    J Clin Microbiol; 2019 Aug 15; 57(8):. PubMed ID: 31167842
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y, Adler A.
    Microb Drug Resist; 2023 Jul 15; 29(7):302-308. PubMed ID: 37219996
    [Abstract] [Full Text] [Related]

  • 7. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.
    J Infect Chemother; 2018 Apr 15; 24(4):315-318. PubMed ID: 29223615
    [Abstract] [Full Text] [Related]

  • 8. Cumulative antimicrobial susceptibilities for respiratory clinical isolates of Mycobacterium avium Complex, Mycobacterium kansasii, and Mycobacterium abscessus from Pakistan 2018 to 2022.
    Shakoor S, Shafiq S, Shahid A, Mir F, Ali R, Hasan R.
    Int J Mycobacteriol; 2023 Apr 15; 12(3):310-315. PubMed ID: 37721238
    [Abstract] [Full Text] [Related]

  • 9. Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints.
    Schön T, Chryssanthou E.
    Int J Infect Dis; 2017 Feb 15; 55():122-124. PubMed ID: 28069470
    [Abstract] [Full Text] [Related]

  • 10. [Antimicrobial susceptibility and genotyping of Mycobacterium intracellulare].
    Wang SQ, Jiang GL, Wei GM, Huo FM, Dong LL, Zhao LP, Huang HR, Wang GR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jul 12; 41(7):539-543. PubMed ID: 29996350
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
    Sirichoat A, Kaewprasert O, Hinwan Y, Faksri K.
    PLoS One; 2023 Jul 12; 18(11):e0294677. PubMed ID: 37992075
    [Abstract] [Full Text] [Related]

  • 12. Difference in drug susceptibility distribution and clinical characteristics between Mycobacterium avium and Mycobacterium intracellulare lung diseases in Shanghai, China.
    Wang W, Yang J, Wu X, Wan B, Wang H, Yu F, Guo Y.
    J Med Microbiol; 2021 May 12; 70(5):. PubMed ID: 33999797
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022.
    Wang DM, Liu H, Zheng YL, Xu YH, Liao Y.
    Front Cell Infect Microbiol; 2023 May 12; 13():1282902. PubMed ID: 38029240
    [Abstract] [Full Text] [Related]

  • 14. Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China.
    Li Y, Liu C, Ma A, He W, Qiu Q, Zhao Y, Li Y.
    J Glob Antimicrob Resist; 2022 Dec 12; 31():90-97. PubMed ID: 35660663
    [Abstract] [Full Text] [Related]

  • 15. Evaluating amikacin minimum inhibitory concentration in trailing growth for Mycobacterium avium complex.
    Park B, Shim TS, Jo KW, Won EJ, Kim MN, Sung H.
    Tuberculosis (Edinb); 2023 Dec 12; 143():102427. PubMed ID: 37918057
    [Abstract] [Full Text] [Related]

  • 16. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    Maya TG, Komba EV, Mensah GI, Mbelele PM, Mpagama SG, Mfinanga SG, Addo KK, Kazwala RR.
    PLoS One; 2022 Dec 12; 17(3):e0265358. PubMed ID: 35324922
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH, Arslan N, Esen N, Özkütük AA.
    Mikrobiyol Bul; 2023 Apr 12; 57(2):220-237. PubMed ID: 37067207
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F, Loiseau J, Veziris N, Bernard C, Bercot B, Sougakoff W, Jarlier V, Raskine L, Cambau E, French National Reference Center for Mycobacteria.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1669-1677. PubMed ID: 28333340
    [Abstract] [Full Text] [Related]

  • 19. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
    Sharma M, Malhotra B, Khandelwal S.
    Indian J Med Microbiol; 2021 Jul 01; 39(3):306-310. PubMed ID: 33846029
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC, Wu MF, Chen HC, Huang WC.
    J Microbiol Immunol Infect; 2018 Oct 01; 51(5):636-643. PubMed ID: 28705770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.